Title: A phase II/III trial for older patients with acute myeloid leukaemia and high risk myelodysplastc syndrome: Intensive Arm - AML 16

Funder
Genzyme Therapeutics Ltd

Principal Investigator

Project Details
Net value award figure for Cardiff University: £5,630,750.00
Start date: 01/08/2006
End date: 30/06/2013

Last updated on 2020-10-06 at 06:01